Akso Health Group Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Akso Health Group income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2019
Period EndingDec 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2019
Revenue & Gross Profit
Revenue14.782.4113.186.000.0061.33
Cost of Revenue15.062.2911.915.390.007.40
Gross Profit-0.280.121.270.610.0053.93
Operating Expenses
Research & Development0.000.000.000.420.000.00
Selling, General & Administrative3.648.7615.543.062.0348.84
Operating Expenses166.028.7615.543.062.0948.84
Operating Income-166.30-8.64-14.27-2.46-2.095.10
Other Income/Expense
Interest Income0.000.000.000.000.000.00
Interest Expense0.000.000.000.80-2.150.00
Other Income/Expense0.03-0.450.06-0.75-0.052.31
Income
Income Before Tax-166.27-9.09-13.07-4.01-4.297.41
Income Tax Expense-30.800.020.020.090.001.87
Net Income-134.98-9.46-1.36-16.85-34.835.53
Net Income - Continuous Operations-134.98-9.12-13.08-4.100.000.00
Net Income - Discontinued Operations0.00-0.4011.84-12.750.000.00
EBITDA-1.77-8.64-14.25-3.20-2.077.81
EBIT-3.92-8.64-14.27-3.20-2.097.41
Depreciation & Amortization2.150.000.020.020.020.00
Earnings Per Share
Basic EPS----1.00-2.00-
Diluted EPS----1.00-2.00-
Basic Shares Outstanding285.1047.1722.8719.8716.2816.23
Diluted Shares Outstanding285.1047.1722.8719.8716.2817.64